Market Place
Sourcing Support
All News #Library
Biotech
MaxCyte Unveils ExPERT DTx to Accelerate Discovery
24 Feb 2026 //
GLOBENEWSWIRE
Maxcyte Reiterates Revenue Guidance After Q3 Financial Update
05 Nov 2025 //
GLOBENEWSWIRE
Maxcyte Inks Strategic License Deal With Moonlight Bio For Tumors
06 Oct 2025 //
GLOBENEWSWIRE
MaxCyte Signs Platform License Agreement with Adicet Bio
04 Aug 2025 //
GLOBENEWSWIRE
MaxCyte, Anocca AB Partner for Advancement of TCR-T Cell Therapy
31 Jul 2025 //
GLOBENEWSWIRE
MaxCyte and Ori Biotech Collaborate to Improve Manufacturing
11 Jun 2025 //
GLOBENEWSWIRE
MaxCyte Reports Q4 and Full Year 2024 Results, Gives 2025 Guidance
11 Mar 2025 //
GLOBENEWSWIRE
MaxCyte Acquires SeQure Dx To Enhance Cell Engineering Capabilities
30 Jan 2025 //
GLOBENEWSWIRE
MaxCyte Streamlines Operations & Raises 2024 Revenue Guidance
09 Dec 2024 //
GLOBENEWSWIRE
MaxCyte Celebrates 25 Years of Cell Engineering Innovation
13 Nov 2024 //
GLOBENEWSWIRE
MaxCyte Reports Q3 2024 Financials & Updates Guidance
06 Nov 2024 //
GLOBENEWSWIRE
MaxCyte to Participate in Two Upcoming Investor Conferences
31 Oct 2024 //
GLOBENEWSWIRE
MaxCyte Appoints Cynthia Collins to its Board of Directors
15 Oct 2024 //
GLOBENEWSWIRE
MaxCyte Appoints Ali Soleymannezhad as Chief Commercial Officer
10 Oct 2024 //
GLOBENEWSWIRE
MaxCyte Signs Platform License With Kamau For Cell Therapy Development
16 Sep 2024 //
GLOBENEWSWIRE
MaxCyte To Participate In Craig-Hallum Bioprocessing Conference
05 Sep 2024 //
GLOBENEWSWIRE
Porton Advanced Introduces MaxCyte ExPERT GTx Flow Electroporation Instrument
25 Jun 2024 //
PR NEWSWIRE
MaxCyte to Participate in William Blair 44th Annual Growth Stock Conference
29 May 2024 //
GLOBENEWSWIRE
MaxCyte, Legend Bio Partner To Accelerate Cell Therapies
22 May 2024 //
GLOBENEWSWIRE
MaxCyte Joins the Alliance for mRNA Medicines (AMM) as a Founding Member
16 Nov 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.